Researchers looked into how natural polysaccharides might work alongside common cancer treatments like pembrolizumab and nivolumab. These substances are being studied for their potential to change the environment around tumors and improve how the immune system functions.
Early findings suggest these compounds might help the body better respond to immunotherapy. This is based on preclinical observations, which are studies done in labs rather than in human patients. The research highlights a potential way to help patients whose bodies do not respond well to standard treatments.
It is important to note that this research is still in the early stages. Because the evidence comes from lab studies and the data is currently fragmented, it is not yet clear how this would work in a clinical setting. More human trials are needed to confirm if these benefits are safe and effective for patients.